3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
3
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Conditions
Ovarian Neoplasms
51
Endometrial Neoplasms
21
Fallopian Tube Neoplasms
17
Sarcoma
9
Peritoneal Neoplasms
9
Neoplasm Metastasis
7
Neoplasms
6
Liposarcoma
6
Leiomyosarcoma
5
Hemangiosarcoma
5
Fibrosarcoma
5
Carcinoma, Ovarian Epithelial
5
Uterine Neoplasms
4
Stomach Neoplasms
4
Sarcoma, Synovial
4
Recurrence
4
Neurofibrosarcoma
4
Malignant mesenchymal tumor
4
Histiocytoma, Malignant Fibrous
4
Desmoplastic Small Round Cell Tumor
4
Colorectal Neoplasms
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Sarcoma, Endometrial Stromal
3
Rhabdomyosarcoma
3
Hemangiopericytoma, Malignant
3
Breast Neoplasms
3
Appendiceal Neoplasms
3
Sarcoma, Alveolar Soft Part
2
Pheochromocytoma
2
Interventions
Early Intervention, Educational
6
Oxaliplatin
5
Methods
4
Cisplatin
4
pembrolizumab
3
Trastuzumab
3
Surveys and Questionnaires
3
Specimen Handling
3
Leucovorin
3
Fluorouracil
3
Carboplatin
3
X-Rays
2
Radiotherapy
2
Observation
2
Magnetic Resonance Spectroscopy
2
Magnetic Resonance Imaging
2
Irinotecan
2
Interleukin-12 Subunit p35
2
Gemcitabine
2
Cyclophosphamide
2
Counseling
2
Cetuximab
2
Capecitabine
2
Biopsy
2
veliparib
1
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
tipifarnib
1
sodium thiosulfate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
Doxorubicin
×
Gynecologic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled